Literature DB >> 17646714

Identification and characterization of two novel variants of the DUF1208 protein FAM92A1.

Xu Zhi Ruan1, Fei Yan, Xin Yu Zhao, Chung Ting Wang, Ming Song, Han Suo Yang, Hong Xin Deng, Yu Quan Wei.   

Abstract

FAM92A1 (named FAM92A1-271) belongs to the family of proteins with conserved DUF1208 domains. Its function remains elusive. We identified two novel transcript variants (FAM92A1-251, FAM92A1-289) of FAM92A1. The presence of these transcripts in cancerous and normal cells, as well as their influence on cell proliferation and apoptosis, were investigated. The subcellular location of FAM92A1 was determined by fluorescence microscopy. We found that FAM92A1-271 and FAM92A1- 289 were highly expressed in both normal and cancerous cells, but FAM92A1-251 was only expressed at a moderate level in both types of cell. Overexpression of FAM92A1-271, FAM92A1-251 and FAM92A1-289 inhibited cell proliferation, caused S-phase arrest and induced apoptosis. Subcellular localization showed that FAM92A1 localizes to the nucleus. Our results show that FAM92A1 has different splicing variants, and that it may take part in regulating cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646714

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  3 in total

1.  BAR Domain-Containing FAM92 Proteins Interact with Chibby1 To Facilitate Ciliogenesis.

Authors:  Feng-Qian Li; Xingwang Chen; Cody Fisher; Saul S Siller; Klara Zelikman; Ryoko Kuriyama; Ken-Ichi Takemaru
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

2.  Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.

Authors:  Xing Rong Guo; Mu Yu Wu; Long Jun Dai; Yu Huang; Meng Ye Shan; Shi Nan Ma; Jue Wang; Hao Peng; Yan Ding; Qiu Fang Zhang; Jun Ming Tang; Xu Zhi Ruan; Dong Sheng Li
Journal:  J Exp Clin Cancer Res       Date:  2019-09-06

3.  BARMR1-mediated sorafenib resistance is derived through stem-like property acquisition by activating integrin-FAK signaling pathways.

Authors:  Xing Rong Guo; Meng Ye Shan; Yu Huang; Zong Li Zhang; Yue Yuan; Long Jun Dai; Jue Wang; Xue Peng Zhou; Fu Yun Ji; Jun Ming Tang; Zhong Ji Meng; Xu Zhi Ruan
Journal:  Signal Transduct Target Ther       Date:  2020-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.